Yang X et al. |
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. |
2001 |
Cancer Res. |
pmid:11585728
|
Wang X et al. |
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. |
2009 |
Cancer Res. |
pmid:19752087
|
Wei M et al. |
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. |
2005 |
Cancer Res. |
pmid:16322213
|
Hatjiharissi E et al. |
Proteomic analysis of waldenstrom macroglobulinemia. |
2007 |
Cancer Res. |
pmid:17440091
|
Fahrner JA et al. |
Dependence of histone modifications and gene expression on DNA hypermethylation in cancer. |
2002 |
Cancer Res. |
pmid:12499261
|
Shah S et al. |
Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. |
2012 |
Cancer Res. |
pmid:22258452
|
Lau QC et al. |
RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. |
2006 |
Cancer Res. |
pmid:16818622
|
Su Y et al. |
Human RecQL4 helicase plays critical roles in prostate carcinogenesis. |
2010 |
Cancer Res. |
pmid:21045146
|
Ibanez de Caceres I et al. |
Identification of novel target genes by an epigenetic reactivation screen of renal cancer. |
2006 |
Cancer Res. |
pmid:16707423
|
Imre G et al. |
Histone deacetylase inhibitors suppress the inducibility of nuclear factor-kappaB by tumor necrosis factor-alpha receptor-1 down-regulation. |
2006 |
Cancer Res. |
pmid:16707469
|
Maecker HL et al. |
p53 promotes selection for Fas-mediated apoptotic resistance. |
2000 |
Cancer Res. |
pmid:10969818
|
Badia E et al. |
Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling. |
2000 |
Cancer Res. |
pmid:10945620
|
Saunders N et al. |
Histone deacetylase inhibitors as potential anti-skin cancer agents. |
1999 |
Cancer Res. |
pmid:9927053
|
Ramsey MR et al. |
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. |
2011 |
Cancer Res. |
pmid:21527555
|
Wilson AJ et al. |
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. |
2002 |
Cancer Res. |
pmid:12414619
|
Majid S et al. |
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. |
2010 |
Cancer Res. |
pmid:20332239
|
Sowa Y et al. |
Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. |
1999 |
Cancer Res. |
pmid:10485470
|
Myzak MC et al. |
A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. |
2004 |
Cancer Res. |
pmid:15313918
|
Xiong Y et al. |
Histone deacetylase inhibitors decrease DNA methyltransferase-3B messenger RNA stability and down-regulate de novo DNA methyltransferase activity in human endometrial cells. |
2005 |
Cancer Res. |
pmid:15805266
|
Kumakura S et al. |
Reversible conversion of immortal human cells from telomerase-positive to telomerase-negative cells. |
2005 |
Cancer Res. |
pmid:15805278
|
Pellicciotta I et al. |
Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. |
2008 |
Cancer Res. |
pmid:18829567
|
Mizutani H et al. |
Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. |
2010 |
Cancer Sci. |
pmid:20624163
|
Sakuma M et al. |
Promoter methylation status of the Cyclin D2 gene is associated with poor prognosis in human epithelial ovarian cancer. |
2007 |
Cancer Sci. |
pmid:17270028
|
Tomosugi M et al. |
Retinoblastoma gene-independent G1 phase arrest by flavone, phosphatidylinositol 3-kinase inhibitor, and histone deacetylase inhibitor. |
2012 |
Cancer Sci. |
pmid:22957647
|
Chikamatsu K et al. |
Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck. |
2013 |
Cancer Sci. |
pmid:23992541
|
Hattori N et al. |
Methylation silencing of angiopoietin-like 4 in rat and human mammary carcinomas. |
2011 |
Cancer Sci. |
pmid:21489049
|
Sasaki K et al. |
Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera. |
2008 |
Cancer Sci. |
pmid:18271940
|
Furumai R et al. |
Histone deacetylase inhibitors block nuclear factor-κB-dependent transcription by interfering with RNA polymerase II recruitment. |
2011 |
Cancer Sci. |
pmid:21299717
|
Yamada Y et al. |
Aberrant methylation of the vascular endothelial growth factor receptor-1 gene in prostate cancer. |
2003 |
Cancer Sci. |
pmid:12824880
|
Okada T et al. |
Identification of genes specifically methylated in Epstein-Barr virus-associated gastric carcinomas. |
2013 |
Cancer Sci. |
pmid:23829175
|
Akao Y et al. |
Downregulation of microRNAs-143 and -145 in B-cell malignancies. |
2007 |
Cancer Sci. |
pmid:17892514
|
Leng SL et al. |
Insulin-like growth factor-II renders LIM 2405 human colon cancer cells resistant to butyrate-induced apoptosis: a potential mechanism for colon cancer cell survival in vivo. |
2001 |
Carcinogenesis |
pmid:11577001
|
Ma J et al. |
Promoter hypermethylation and histone hypoacetylation contribute to pancreatic-duodenal homeobox 1 silencing in gastric cancer. |
2010 |
Carcinogenesis |
pmid:20622005
|
Kim YH et al. |
Sodium butyrate sensitizes TRAIL-mediated apoptosis by induction of transcription from the DR5 gene promoter through Sp1 sites in colon cancer cells. |
2004 |
Carcinogenesis |
pmid:15142888
|
Gastaldi T et al. |
Plakoglobin is differentially expressed in alveolar and embryonal rhabdomyosarcoma and is regulated by DNA methylation and histone acetylation. |
2006 |
Carcinogenesis |
pmid:16537559
|
Grassi G et al. |
Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. |
2003 |
Carcinogenesis |
pmid:12869421
|
Kwon O et al. |
NF-kappaB inhibition increases chemosensitivity to trichostatin A-induced cell death of Ki-Ras-transformed human prostate epithelial cells. |
2006 |
Carcinogenesis |
pmid:16774937
|
Chen CQ et al. |
Pure curcumin increases the expression of SOCS1 and SOCS3 in myeloproliferative neoplasms through suppressing class I histone deacetylases. |
2013 |
Carcinogenesis |
pmid:23430957
|
Thakur VS et al. |
Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. |
2012 |
Carcinogenesis |
pmid:22114073
|
Sharma A et al. |
Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. |
2013 |
Carcinogenesis |
pmid:23880304
|
Derks S et al. |
Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. |
2009 |
Carcinogenesis |
pmid:19329758
|
Jensen TJ et al. |
Epigenetic remodeling during arsenical-induced malignant transformation. |
2008 |
Carcinogenesis |
pmid:18448484
|
Bhakat KK and Mitra S |
CpG methylation-dependent repression of the human O6-methylguanine-DNA methyltransferase gene linked to chromatin structure alteration. |
2003 |
Carcinogenesis |
pmid:12807730
|
Xiang N et al. |
Selenite reactivates silenced genes by modifying DNA methylation and histones in prostate cancer cells. |
2008 |
Carcinogenesis |
pmid:18676679
|
Nandakumar V et al. |
(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells. |
2011 |
Carcinogenesis |
pmid:21209038
|
Liu T et al. |
Regulation of Cdx2 expression by promoter methylation, and effects of Cdx2 transfection on morphology and gene expression of human esophageal epithelial cells. |
2007 |
Carcinogenesis |
pmid:16990345
|
Kamitani H et al. |
Expression of 15-lipoxygenase-1 is regulated by histone acetylation in human colorectal carcinoma. |
2001 |
Carcinogenesis |
pmid:11159758
|
Kaichi S et al. |
Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. |
2010 |
Cardiovasc. Res. |
pmid:20547733
|
Becker JR et al. |
In vivo natriuretic peptide reporter assay identifies chemical modifiers of hypertrophic cardiomyopathy signalling. |
2012 |
Cardiovasc. Res. |
pmid:22198505
|
Zhao TC et al. |
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury. |
2007 |
Cardiovasc. Res. |
pmid:17884027
|